275 related articles for article (PubMed ID: 30025711)
1. Genomic Characterization of Testicular Germ Cell Tumors Relapsing After Chemotherapy.
Necchi A; Bratslavsky G; Corona RJ; Chung JH; Millis SZ; Elvin JA; Vergilio JA; Suh J; Ramkissoon S; Severson E; Daniel S; Killian JK; Ali SM; Schrock AB; Reddy P; Miller VA; Welsh A; Gay LM; Ross JS
Eur Urol Focus; 2020 Jan; 6(1):122-130. PubMed ID: 30025711
[TBL] [Abstract][Full Text] [Related]
2. Genomic Features of Metastatic Testicular Sex Cord Stromal Tumors.
Necchi A; Bratslavsky G; Shapiro O; Elvin JA; Vergilio JA; Killian JK; Ngo N; Ramkissoon S; Severson E; Hemmerich AC; Ali SM; Chung JH; Reddy P; Miller VA; Schrock AB; Gay LM; Ross JS; Jacob JM
Eur Urol Focus; 2019 Sep; 5(5):748-755. PubMed ID: 31147264
[TBL] [Abstract][Full Text] [Related]
3. Genomic Features for Therapeutic Insights of Chemotherapy-Resistant, Primary Mediastinal Nonseminomatous Germ Cell Tumors and Comparison with Gonadal Counterpart.
Necchi A; Bratslavsky G; Chung J; Millis S; Gay LM; Ali SM; Ross JS
Oncologist; 2019 Apr; 24(4):e142-e145. PubMed ID: 30659078
[TBL] [Abstract][Full Text] [Related]
4. Microsatellite instability, mismatch repair deficiency, and BRAF mutation in treatment-resistant germ cell tumors.
Honecker F; Wermann H; Mayer F; Gillis AJ; Stoop H; van Gurp RJ; Oechsle K; Steyerberg E; Hartmann JT; Dinjens WN; Oosterhuis JW; Bokemeyer C; Looijenga LH
J Clin Oncol; 2009 May; 27(13):2129-36. PubMed ID: 19289622
[TBL] [Abstract][Full Text] [Related]
5. Assessment of piRNA biogenesis and function in testicular germ cell tumors and their precursor germ cell neoplasia in situ.
Gainetdinov IV; Skvortsova YV; Kondratieva SA; Klimov A; Tryakin AA; Azhikina TL
BMC Cancer; 2018 Jan; 18(1):20. PubMed ID: 29301509
[TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity of selected tumor suppressor genes in human testicular germ cell tumors.
Vladusić T; Hrasćan R; Vrhovac I; Kruslin B; Gamulin M; Grgić M; Pećina-Slaus N; Franekić Colić J
Pathol Res Pract; 2010 Mar; 206(3):163-7. PubMed ID: 20092957
[TBL] [Abstract][Full Text] [Related]
7. Disparities in stage at diagnosis among adults with testicular germ cell tumors in the National Cancer Data Base.
Lerro CC; Robbins AS; Fedewa SA; Ward EM
Urol Oncol; 2014 Jan; 32(1):23.e15-21. PubMed ID: 23395701
[TBL] [Abstract][Full Text] [Related]
8. Aberrant epigenetic inactivation of RASSF1A and MGMT gene and genetic mutations of KRAS, cKIT and BRAF in Indian testicular germ cell tumours.
Ahmad F; Surve P; Natarajan S; Patil A; Pol S; Patole K; Das BR
Cancer Genet; 2020 Feb; 241():42-50. PubMed ID: 31653608
[TBL] [Abstract][Full Text] [Related]
9. Mutations of BRAF and RAS are rare events in germ cell tumours.
Sommerer F; Hengge UR; Markwarth A; Vomschloss S; Stolzenburg JU; Wittekind C; Tannapfel A
Int J Cancer; 2005 Jan; 113(2):329-35. PubMed ID: 15386408
[TBL] [Abstract][Full Text] [Related]
10. RAS/MAPK Pathway Driver Alterations Are Significantly Associated With Oncogenic KIT Mutations in Germ-cell Tumors.
Mata DA; Yang SR; Ferguson DC; Liu Y; Sharma R; Benhamida JK; Al-Ahmadie HA; Chakravarty D; Solit DB; Tickoo SK; Gupta S; Arcila ME; Ladanyi M; Feldman DR; Reuter VE; Vanderbilt CM
Urology; 2020 Oct; 144():111-116. PubMed ID: 32721511
[TBL] [Abstract][Full Text] [Related]
11. IGF1R signalling in testicular germ cell tumour cells impacts on cell survival and acquired cisplatin resistance.
Selfe J; Goddard NC; McIntyre A; Taylor KR; Renshaw J; Popov SD; Thway K; Summersgill B; Huddart RA; Gilbert DC; Shipley JM
J Pathol; 2018 Feb; 244(2):242-253. PubMed ID: 29160922
[TBL] [Abstract][Full Text] [Related]
12. Genes, chromosomes and the development of testicular germ cell tumors of adolescents and adults.
McIntyre A; Gilbert D; Goddard N; Looijenga L; Shipley J
Genes Chromosomes Cancer; 2008 Jul; 47(7):547-57. PubMed ID: 18381640
[TBL] [Abstract][Full Text] [Related]
13. Characterization of testicular germ cell tumors: Whole-lesion histogram analysis of the apparent diffusion coefficient at 3T.
Min X; Feng Z; Wang L; Cai J; Yan X; Li B; Ke Z; Zhang P; You H
Eur J Radiol; 2018 Jan; 98():25-31. PubMed ID: 29279166
[TBL] [Abstract][Full Text] [Related]
14. Histopathological and molecular features of late relapses in non-seminomas.
Mayer F; Wermann H; Albers P; Stoop H; Gillis AJ; Hartmann JT; Bokemeyer CC; Oosterhuis JW; Looijenga LH; Honecker F
BJU Int; 2011 Mar; 107(6):936-43. PubMed ID: 20955261
[TBL] [Abstract][Full Text] [Related]
15. [Urologic treatment of testicular germ cell cancer].
Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
[TBL] [Abstract][Full Text] [Related]
16. Exome-wide Sequencing Shows Low Mutation Rates and Identifies Novel Mutated Genes in Seminomas.
Cutcutache I; Suzuki Y; Tan IB; Ramgopal S; Zhang S; Ramnarayanan K; Gan A; Lee HH; Tay ST; Ooi A; Ong CK; Bolthouse JT; Lane BR; Anema JG; Kahnoski RJ; Tan P; Teh BT; Rozen SG
Eur Urol; 2015 Jul; 68(1):77-83. PubMed ID: 25597018
[TBL] [Abstract][Full Text] [Related]
17. Distinct epigenetic phenotypes in seminomatous and nonseminomatous testicular germ cell tumors.
Smiraglia DJ; Szymanska J; Kraggerud SM; Lothe RA; Peltomäki P; Plass C
Oncogene; 2002 May; 21(24):3909-16. PubMed ID: 12032829
[TBL] [Abstract][Full Text] [Related]
18. Molecular and cell biology of testicular germ cell tumors.
Chieffi P; Franco R; Portella G
Int Rev Cell Mol Biol; 2009; 278():277-308. PubMed ID: 19815181
[TBL] [Abstract][Full Text] [Related]
19. Chromosomes and expression in human testicular germ-cell tumors: insight into their cell of origin and pathogenesis.
Looijenga LH; Gillis AJ; Stoop HJ; Hersmus R; Oosterhuis JW
Ann N Y Acad Sci; 2007 Dec; 1120():187-214. PubMed ID: 17911410
[TBL] [Abstract][Full Text] [Related]
20. Promoter methylation of DNA homologous recombination genes is predictive of the responsiveness to PARP inhibitor treatment in testicular germ cell tumors.
Lobo J; Constâncio V; Guimarães-Teixeira C; Leite-Silva P; Miranda-Gonçalves V; Sequeira JP; Pistoni L; Guimarães R; Cantante M; Braga I; Maurício J; Looijenga LHJ; Henrique R; Jerónimo C
Mol Oncol; 2021 Apr; 15(4):846-865. PubMed ID: 33513287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
